Advances in Checkpoints Immunology from Autoimmunity to Oncology to Infectious Diseases
joint with Cancer Neoantigens, Vaccines and Viruses
Scientific Organizers: David M. Lee, Arlene H. Sharpe and William H. Robinson
Date: February 06 - 10, 2022
Location: Fairmont Banff Springs, Banff, AB, Canada
For important information on the coronavirus, please click here
Understanding of the mechanisms by which checkpoints regulate immune responses is burgeoning; molecular insights into checkpoint signaling, and complexities regarding degrees of checkpoint regulation in immune exhaustion vs. immune homeostasis are coming to light. The use of checkpoint antagonist therapeutics in Oncology has ushered in a transformation for treatment and led to major leaps in our understanding of checkpoint functions, both in health and in the context of immune responses to tumors. There are also rapidly emerging insights into the role of checkpoints in immune dysfunction seen in Autoimmune diseases, and checkpoint-targeted therapies for Autoimmune diseases are now in clinical studies. Further, treatment-associated autoimmunity syndromes comprise an important adverse event for cancer immunotherapy. While these syndromes are currently poorly understood, their analysis promises to shed new insights into improving tolerability of cancer treatment as well as into immune dysfunction in Autoimmune diseases. The meeting will provide a forum for cross-fertilization across disciplines, with a particular focus on Autoimmunity and will also include opportunities that stimulate new directions for investigation in Oncology and other diseases.
Scholarship Deadline: October 20 2021 details
Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies
Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.